Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yumiko Arisue"'
Autor:
Yumiko Arisue, Makoto Muramatsu
Publikováno v:
YAKUGAKU ZASSHI. 132:733-752
We analyzed the target enzymes of drugs containing new active ingredients (NAIs) focusing on the characteristics of the reaction of the enzymes, and attempted to prepare a comprehensive overview of the changes in the approval of the drugs over a 3 de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81d3443dc81f3a75ec9cce146d59988
https://doi.org/10.1248/yakushi.132.733
https://doi.org/10.1248/yakushi.132.733
Autor:
Koji Fukuda, Yuko Kinoshita, Keiko Yoshida, David Kingdon, Scott Harris, Shutaro Nakaaki, Kazuma Saka, Toshi A. Furukawa, David Dayson, Kuni Kinoshita, Yumiko Arisue, Yoshihiro Kinoshita
Publikováno v:
Social Psychiatry and Psychiatric Epidemiology. 46:703-710
A number of recent studies suggest that delusions may be explained as a continuum from normal beliefs. Fear of negative evaluation from others (FNE) is one of potential factors that might describe this psychological process of delusions.In order to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a669bd9b53605076a454c8bdc46ffe0b
https://doi.org/10.1007/s00127-010-0237-8
https://doi.org/10.1007/s00127-010-0237-8
Autor:
Makoto, Muramatsu, Yumiko, Arisue
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 131(4)
We analyzed the therapeutic target molecules and biochemical properties of 893 new drugs with new molecular entities approved over three decades from 1980 to 2009 in Japan. According to our analysis of the therapeutic targets, 26.2% of new drugs were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db930d5a84169ccdf8a5bd5e3711b928
https://pubmed.ncbi.nlm.nih.gov/21467801
https://pubmed.ncbi.nlm.nih.gov/21467801
Autor:
Ken-ichi Sako, Shunsuke Yano, Masayuki Kimura, Yoshihiko Matsuki, Hirohisa Doi, Yoshikazu Matsuda, Tohru Kishino, Yumiko Arisue, Mayumi Hasegawa, Takeshi Kawamura, Hisao Haniu, Yuichiro Oosawa
Publikováno v:
Journal of Bioequivalence & Bioavailability.
Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation can be an invaluable tool for use in making crucial decisions in drug development and clinical settings, including those pertaining to compound selection, dose selection, study design, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1ad162ce897069bcb61e5cb02973eb7
https://doi.org/10.4172/jbb.s2-002
https://doi.org/10.4172/jbb.s2-002